BRIDGE PCP: Cancer Screening Edition

This activity is offered as an on-demand direct recording from the October 9, 2024 Grand Rounds presentation at Albert Einstein College of Medicine-Montefiore Medical Center.

COURSE DESCRIPTION

With more than 2 million new cases to be diagnosed and 609,000 deaths expected in 2024, cancer presents enormous medical, economic, and social burdens. Social determinants of health play a role in the burdens of cancer: men, non-Hispanic Blacks, and people who are economically disadvantaged have higher rates of cancer, experience greater disease burdens, and have higher mortality rates compared with other groups. Identifying cancer at its earliest stages can improve these outcomes by allowing therapy to begin sooner, reducing treatment costs and complexity, minimizing morbidity, and improving quality of life. Primary care clinicians and other frontline providers are well positioned to optimize cancer screening awareness and uptake, with the goal of earlier cancer detection and significant improvements in the racial, ethnic, and socioeconomic disparities associated with cancer screening. This activity will educate clinicians on the state of cancer screening in the US, with a focus on the Bronx, NY; how to recognize and address real-world barriers to cancer screening, particularly in underserved populations; and the science behind blood-based multi-cancer early detection tests and their potential use in individuals who are at higher risk of morbidity and mortality from cancer, particularly cancer types with limited or inaccessible screening methods.

LEARNING OBJECTIVES

• Discuss socioeconomic, racial, ethnic, and cultural barriers to preventive cancer screening for underserved populations and how to reduce them
• Characterize the role of blood-based cancer screening in early cancer detection, including recent clinical trial and real-world data on available and emerging blood-based MCED screening tests
• Describe strategies to introduce MCED screening into clinical practice, including patient eligibility criteria and shared decision-making
• Educate patients on the cancer screening initiatives available

ACCREDITATION STATEMENT

In support of improving patient care, Albert Einstein College of Medicine-Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CREDIT DESIGNATION STATEMENTS

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credits* for learning and change.

*For physicians, this is the number of AMA PRA Category 1 Credits™ awarded.

Albert Einstein College of Medicine-Montefiore Medical Center designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine-Montefiore Medical Center designates this activity for 1.0 nursing contact hours.  Nurses should claim only credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine-Montefiore Medical Center has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must:

• Read the educational objectives, accreditation information, and faculty disclosures at the beginning of this activity.
• Complete the Preactivity Questions.
• Review the activity content.
• Achieve a grade of at least 70% on the Postactivity Test Questions and complete the Evaluation.

FINANCIAL DISCLOSURES

The “Policy on Identification, Mitigation and Disclosure of Relevant Financial Relationships” of Albert Einstein College of Medicine-Montefiore Medical Center requires that any individual in control of content, including faculty, participating in CME/CE activities disclose to the audience all relevant financial relationships with ineligible companies* in the last 24 months. Any individual in control of content who refuses to disclose, or their disclosed relationships prove to create a conflict of interest will be recused.

Individuals with the absence of relevant financial relationships with ineligible companies will be disclosed to the audience. 

All financial relationships of individual(s) in a position to control the content of this CME/CE activity has been identified and mitigated prior to this educational activity. 

*The ACCME defines an ineligible company as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

FACULTY PRESENTER

Carmen Guerra, MD, MSCE, FACP has received grant funds for serving as a principal investigator (Funds paid to institution) from Genentech and has received consultant fees for serving as a scientific advisor from Guardant Health. Guardant Health business line and/or product is relevant to Dr. Guerra’s presentation.

FACULTY MODERATOR AND CONTENT REVIEWER

T. S. Dharmarajan, MD, MACP has reported no relevant financial relationships with ACCME-defined ineligible companies during the past 24 months.

NURSE CONTENT REVIEWER

Una T. Hopkins DNP, RN, FNP-BC, NE-BC, FACCC has reported no relevant financial relationships with ACCME-defined ineligible companies during the past 24 months.